News
Towards an in vitro assay for fibrosis research - Sygnature Discovery
www.sygnaturediscovery.com
Sygnature, we’re developing a suite of 2D and 3D multicellular models of organ fibrosis that can support client drug discovery project in vitro screening.
aba - Herbsttagung Rückblick | Institutional Moneywww.institutional-money.com › galerie › galerieseite
www.institutional-money.com
Dr. Erika Biedlingmeier, Nina Schroeder, beide Allianz Lebensversicherung, Boris Berning, Tower Watson, Dr. Dennis Hagedorn, Allianz Lebensversicherung.
sortiert nach Relevanz / Datum